Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
NCT00697515
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
142
Enrollment
INDUSTRY
Sponsor class
Conditions
ADHD
Interventions
DRUG:
LDX
DRUG:
Placebo
Sponsor
Shire